Ipsen acquires Memo Therapeutics for up to $800 million
Ipsen acquires Memo Therapeutics for up to $800 million
Ipsen acquires Memo Therapeutics for up to $800 million
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.